BBP
BBP
About Virtus Biotech ETF
The Fund seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Products Index, which tracks the performance of biotechnology companies with at least one drug therapy approved by the FDA.Effective February 27, this Fund's name changed from Virtus LifeSci Biotech Products ETF to Virtus Biotech ETF.
About Virtus Biotech ETF
The Fund seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Products Index, which tracks the performance of biotechnology companies with at least one drug therapy approved by the FDA.Effective February 27, this Fund's name changed from Virtus LifeSci Biotech Products ETF to Virtus Biotech ETF.
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
 IBRX | ImmunityBio, Inc. | 4.80% | 385.41K | $2.93M |
 DAWN | Day One Biopharmaceuticals, Inc. | 3.83% | 108.80K | $2.33M |
 MRNA | Moderna, Inc. | 2.67% | 30.87K | $1.63M |
 IOVA | Iovance Biotherapeutics, Inc. | 2.47% | 413.44K | $1.50M |
 APLS | Apellis Pharmaceuticals, Inc. | 2.41% | 36.05K | $1.47M |
 MIRM | Mirum Pharmaceuticals, Inc. | 2.22% | 13.99K | $1.36M |
 ROIV | Roivant Sciences Ltd. | 1.97% | 41.16K | $1.20M |
 GERN | Geron Corporation | 1.94% | 668.80K | $1.18M |
 BCRX | BioCryst Pharmaceuticals, Inc. | 1.91% | 120.15K | $1.16M |
 NVAX | Novavax, Inc. | 1.90% | 138.44K | $1.16M |
 AXSM | Axsome Therapeutics, Inc. | 1.85% | 6.14K | $1.13M |
 ZLAB | Zai Lab Limited | 1.84% | 51.19K | $1.12M |
 LGND | Ligand Pharmaceuticals Incorporated | 1.83% | 4.80K | $1.11M |
 AGIO | Agios Pharmaceuticals, Inc. | 1.82% | 33.35K | $1.11M |
 TVTX | Travere Therapeutics, Inc. | 1.80% | 26.11K | $1.10M |
 KALV | KalVista Pharmaceuticals, Inc. | 1.79% | 53.79K | $1.09M |
 SNDX | Syndax Pharmaceuticals, Inc. | 1.79% | 44.65K | $1.09M |
 GILD | Gilead Sciences, Inc. | 1.74% | 7.55K | $1.06M |
 UTHR | United Therapeutics Corporation | 1.74% | 1.84K | $1.06M |
 ASND | Ascendis Pharma A/S | 1.69% | 4.13K | $1.03M |
SECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States
United Kingdom
China
Bermuda
Denmark
Germany
Canada
Switzerland
Cayman IslandsSECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States United Kingdom China Bermuda Denmark Germany Canada Switzerland Cayman IslandsHoldings (Top 20)
IBRX
ImmunityBio, Inc.
DAWN
Day One Biopharmaceuticals, Inc.
MRNA
Moderna, Inc.
IOVA
Iovance Biotherapeutics, Inc.
APLS
Apellis Pharmaceuticals, Inc.
MIRM
Mirum Pharmaceuticals, Inc.
ROIV
Roivant Sciences Ltd.
GERN
Geron Corporation
BCRX
BioCryst Pharmaceuticals, Inc.
NVAX
Novavax, Inc.
AXSM
Axsome Therapeutics, Inc.
ZLAB
Zai Lab Limited
LGND
Ligand Pharmaceuticals Incorporated
AGIO
Agios Pharmaceuticals, Inc.
TVTX
Travere Therapeutics, Inc.
KALV
KalVista Pharmaceuticals, Inc.
SNDX
Syndax Pharmaceuticals, Inc.
GILD
Gilead Sciences, Inc.
UTHR
United Therapeutics Corporation
ASND
Ascendis Pharma A/S